Overview
Alexandra Kalashnikova practices practicing medicine in Saint Petersburg, Russian Federation.
Her clinical expertise encompasses Secondary Immunodeficiency (SID) and Mononucleosis.
She is actively involved in clinical research, co-authoring 12 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Alexandra M. Kalashnikova
Is Alexandra M. Kalashnikova a top-rated expert for Secondary Immunodeficiency (SID)?
MediFind is an objective health platform that identifies experts based on real-world data. Alexandra M. Kalashnikova is classified as an Experienced expert for Secondary Immunodeficiency (SID), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Alexandra M. Kalashnikova participate in research or clinical trials?
Yes. Alexandra M. Kalashnikova has published 12 articles and abstracts on conditions like Secondary Immunodeficiency (SID). You can view a list of Alexandra M. Kalashnikova's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- MononucleosisMs. Kalashnikova isExperienced. Learn about Mononucleosis.
- Secondary Immunodeficiency (SID)Ms. Kalashnikova isExperienced. Learn about Secondary Immunodeficiency (SID).